Report Highlights
Global Pulmonary Drug Delivery Devices Market: Overview
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global pulmonary drug delivery devices market with respect to the leading market segments based on major products, key applications, distribution channels, and geographies.
Global Pulmonary Drug Delivery Devices Market: Segmentation
The global pulmonary drug delivery devices market has been studied based on major product type, application segments, major distribution channels, and regional as well as national markets. Based on product type, the global market has been categorized into three major segments: Dry Powder Inhalers, Metered Dose Inhalers and Nebulizers. Based on application, the global market has been categorized into four segments: Asthma, COPD, cystic fibrosis, and others. Based on distribution channels, the global market has been categorized into three key segments: retail pharmacies, hospital pharmacies, and e-commerce.
The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn for the period from 2014 to 2019 along with the compound annual growth rate (CAGR %) from 2017 to 2019 are provided for all segments, considering 2016 as the base year.
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global pulmonary drug delivery devices market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different products / applications / distribution channels / geographies.
Global Pulmonary Drug Delivery Devices Market: Regional Analysis
Geographically, the pulmonary drug delivery devices market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). Each regional market for pulmonary drug delivery devices market has been further categorized into major product, application, and end-user segments considered within the scope of the study.
Key country (U.S., Japan, Germany, France, U.K., Australia, Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report. Market revenue in terms of US$ Mn for the period from 2014 to 2019 along with CAGR % from 2017 to 2019 are provided for all the regions and nations considering 2016 as the base year.
Global Pulmonary Drug Delivery Devices Market: Competitive Outlook
The competitive scenario among different market players is evaluated through market share analysis in the competition landscape section of the pulmonary drug delivery devices market report. The section also includes competition matrix that analyzes the competition among some of the top global players operating in the market. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global pulmonary drug delivery devices market.
The report also profiles key players operating in the pulmonary drug delivery devices market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include AstraZeneca plc, Novartis AG, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Merck & Co., Inc, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, 3M Healthcare, Omron Corporation, and others.
- Table 1 : Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Product Type, 2016–2024
- Table 2 : Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler), 2016–2024
- Table 3 : Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler), 2016–2024
- Table 4 : Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Nebulizer), 2016–2024
- Table 5 : Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
- Table 6 : Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2014–2024
- Table 7 : Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Region, 2016–2024
- Table 8 : North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016–2024
- Table 9 : North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Dry Powder Inhalers (Product) 2016–2024
- Table 10 : North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Metered Dose Inhalers (Product) 2016–2024
- Table 11 : North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Nebulizers (Product) 2016–2024
- Table 12 : North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
- Table 13 : North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel 2016–2024
- Table 14 : North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Country, 2016–2024
- Table 15 : Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016–2024
- Table 16 : Europe Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2016–2024
- Table 17 : Europe Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2016–2024
- Table 18 : Europe Pulmonary Drug Delivery Devices and Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2016–2024
- Table 19 : Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
- Table 20 : Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2016–2024
- Table 21 : Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country, 2016–2024
- Table 22 : Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016–2024
- Table 23 : Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2016–2024
- Table 24 : Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2016–2024
- Table 25 : Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2016–2024
- Table 26 : Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
- Table 27 : Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2016–2024
- Table 28 : Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country, 2016–2024
- Table 29 : Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016–2024
- Table 30 : Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2016–2024
- Table 31 : Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2016–2024
- Table 32 : Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2016–2024
- Table 33 : Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
- Table 34 : Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2016–2024
- Table 35 : Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Country, 2016–2024
- Table 36 : Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016–2024
- Table 37 : Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2016–2024
- Table 38 : Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2016–2024
- Table 39 : Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2016–2024
- Table 40 : Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
- Table 41 : Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2016–2024
- Table 42 : Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country, 2016–2024
- Figure 1 : Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2016 and 2024
- Figure 2 : Global Dry Powder Inhalers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
- Figure 3 : Global Dry Powder Inhalers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
- Figure 4 : Global Metered Dose Inhalers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2015–2024
- Figure 5 : Global Metered Dose Inhalers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
- Figure 6 : Global Nebulizers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2015–2024
- Figure 7 : Global Nebulizers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
- Figure 8 : Global Single Dose Inhaler Market Volume and Y-o-Y Growth (%), 2015–2024
- Figure 9 : Global Multi Dose Inhaler Market Volume and Y-o-Y Growth (%), 2014–2024
- Figure 10 : Global Manually-actuated pressurized inhaler Market Volume and Y-o-Y Growth (%), 2015–2024
- Figure 11 : Global Breath-actuated pressurized inhaler Market Volume and Y-o-Y Growth (%), 2014–2024
- Figure 12 : Global Jet Nebulizers Market Volume and Y-o-Y Growth (%), 2015–2024
- Figure 13 : Global Ultrasonic Wave Nebulizers Market Volume and Y-o-Y Growth (%), 2014–2024
- Figure 14 : Global Vibrating Mesh Nebulizers Market Volume and Y-o-Y Growth (%), 2014–2024
- Figure 15 : Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type
- Figure 16 : Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2016 and 2024
- Figure 17 : Global Asthma Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
- Figure 18 : Asthma Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
- Figure 19 : Global COPD Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
- Figure 20 : COPD Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
- Figure 21 : Global Cystic Fibrosis Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
- Figure 22 : Cystic Fibrosis Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
- Figure 23 : Global Others Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
- Figure 24 : Others Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
- Figure 25 : Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application
- Figure 26 : Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2016 and 2024
- Figure 27 : Global Retail Pharmacies Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
- Figure 28 : Retail Pharmacies Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
- Figure 29 : Global Hospital Pharmacies Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
- Figure 31 : Global E-commerce Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
- Figure 32 : E-commerce Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
- Figure 33 : Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel
- Figure 34 : Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Region, 2016 and 2024
- Figure 35 : Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Region
- Figure 36 : North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2016–2024
- Figure 37 : North America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
- Figure 38 : North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country
- Figure 39 : North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product, 2016 and 2024
- Figure 40 : North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2016 and 2024
- Figure 41 : North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2016 and 2024
- Figure 42 : North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2016 and 2024
- Figure 43 : North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product
- Figure 44 : North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application
- Figure 45 : North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel
- Figure 46 : Europe Pulmonary drug delivery devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2016–2024
- Figure 47 : Europe Pulmonary drug delivery devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
- Figure 48 : Europe Pulmonary drug delivery devices Market Attractiveness Analysis, by Country
- Figure 49 : Europe Market Value Share Analysis, by Product Type, 2016 and 2024
- Figure 50 : Europe Market Value Share Analysis, by Application, 2016 and 2024
- Figure 51 : Europe Market Value Share Analysis, by Distribution Channel, 2016 and 2024
- Figure 52 : Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2016 and 2024
- Figure 53 : Europe Market Attractiveness Analysis, by Product Type
- Figure 54 : Europe Market Attractiveness Analysis, by Application
- Figure 55 : Europe Market Attractiveness Analysis, by Distribution Channel
- Figure 56 : Asia Pacific Pulmonary drug delivery devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2016–2024
- Figure 57 : Asia Pacific Pulmonary drug delivery devices Market Y-o-Y Analysis, by Country
- Figure 58 : Asia Pacific Market Attractiveness Analysis, by Country
- Figure 59 : Asia Pacific Market Value Share Analysis, by Product Type, 2016 and 2024
- Figure 60 : Asia Pacific Market Value Share Analysis, by Application, 2016 and 2024
- Figure 61 : Asia Pacific Market Value Share Analysis, by Distribution Channel, 2016 and 2024
- Figure 62 : Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2016 and 2024
- Figure 63 : Asia Pacific Market Attractiveness Analysis, by Product Type
- Figure 64 : Asia Pacific Market Attractiveness Analysis, by Application
- Figure 65 : Asia Pacific Market Attractiveness Analysis, by Distribution Channel
- Figure 66 : Latin Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million units) Forecast, 2016–2024
- Figure 67 : Latin America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
- Figure 68 : Latin America Market Attractiveness Analysis, by Country
- Figure 69 : Latin America Market Value Share Analysis, by Product Type, 2016 and 2024
- Figure 70 : Latin America Market Value Share Analysis, by Application, 2016 and 2024
- Figure 71 : Latin America Market Value Share Analysis, by Distribution Channel, 2016 and 2024
- Figure 72 : Latin America Market Value Share Analysis, by Country, 2016 and 2024
- Figure 73 : Latin America Market Attractiveness Analysis, by Product Type
- Figure 74 : Latin America Market Attractiveness Analysis, by Application
- Figure 75 : Latin America Market Attractiveness Analysis, by Distribution Channel
- Figure 76 : MEA Market Size Value (US$ Mn) and Volume (Million Units) Forecast, 2016–2024
- Figure 77 : MEA Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
- Figure 78 : Middle East & Africa Market Attractiveness Analysis, by Country
- Figure 79 : Middle East & Africa Market Value Share Analysis, by Product Type, 2016 and 2024
- Figure 80 : Middle East & Africa Market Value Share Analysis, by Application, 2016 and 2024
- Figure 81 : Middle East & Africa Market Value Share Analysis, by Distribution Channel, 2016 and 2024
- Figure 82 : Middle East & Africa Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2016 and 2024
- Figure 83 : Middle East & Africa Market Attractiveness Analysis, by Product Type
- Figure 84 : Middle East & Africa Market Attractiveness Analysis, by Application
- Figure 85 : Middle East & Africa Market Attractiveness Analysis, by Distribution Channel
- Figure 86 : Global Pulmonary Drug Delivery Devices Market Share Analysis, by Company (2015)
Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More